Denali Therapeutics DNLI
NASDAQ DNLI
$18.41 -0.27 (-1.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Sale and Maturity of Investments (2017 - 2026)

Updated

Analysis

Denali Therapeutics (DNLI) Sale and Maturity of Investments (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Denali Therapeutics 2.94 Bn -473.14 Mn 3.51 Mn 197.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.03 Mn
Mar 31, 2026 220.00 Mn
Dec 31, 2025 275.00 Mn
Sep 30, 2025 107.08 Mn
Jun 30, 2025 162.21 Mn
Mar 31, 2025 161.75 Mn
Dec 31, 2024 351.00 Mn
Sep 30, 2024 198.00 Mn
Jun 30, 2024 225.00 Mn
Mar 31, 2024 383.12 Mn
Dec 31, 2023 489.00 Mn
Sep 30, 2023 601.12 Mn
Jun 30, 2023 552.04 Mn
Mar 31, 2023 433.79 Mn
Dec 31, 2022 364.00 Mn
Sep 30, 2022 144.34 Mn
Jun 30, 2022 232.65 Mn
Mar 31, 2022 250.50 Mn
Dec 31, 2021 193.75 Mn
Sep 30, 2021 293.06 Mn
API Access

Denali Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=DNLI&period=max&api_key=YOUR_API_KEY